Suppliers / Kck Pharmaceutical Industries

Kck Pharmaceutical Industries

Malaysia Updated 9 July 2026

Kck Pharmaceutical Industries is a finished-dose manufacturer based in Malaysia. It appears in 83 regulatory filings across 1 regulator, without an active US DMF or CEP on file.

0
active US DMFs
0
valid CEPs
0
registered plants
83
filings across 1 regulators

Filings and GMP by regulator

Regulator Filings GMP certificates
NPRA (MY) 83 None

Limited public record

Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.

Questions about Kck Pharmaceutical Industries

Does Kck Pharmaceutical Industries hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Kck Pharmaceutical Industries. It does have 83 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Kck Pharmaceutical Industries file?
Filings are on record with NPRA (MY), 83 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Kck Pharmaceutical Industries comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Duopharma M Sdn Bhd also in Malaysia Hovid Bhd also in Malaysia Pharmaniaga Lifescience also in Malaysia Xepa-Soul Pattinson (Malaysia) Sdn Bhd also in Malaysia Novugen Pharma Malaysia Sdn Bhd also in Malaysia

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability